阿里健康(00241.HK)完成收購阿里媽媽醫療健康類目獨家營銷權
阿里健康(00241.HK)公布,有關以135.12億元向控股股東阿里巴巴(09988.HK)收購阿里媽媽醫療健康類目的獨家營銷審核權及附屬權利,購股協議下建議收購事項之所有先決條件已獲達成,且交割已於昨日(17日)根據購股協議之條款及條件作實。
據此,合共25.58億股對價股份已按每股4.5元之發行價配發及發行予賣方,而目標公司已成為公司之全資附屬。公司將根據相關適用法律及法規向中國監管機構備案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.